Maribel Reyes

Maribel Reyes, PhD has a diverse and extensive work experience in the field of clinical pharmacology. Currently, they are the VP, Clinical Pharmacology at Vir Biotechnology, Inc., where they lead a team and provides scientific and strategic expertise in clinical development. Prior to this, they served as the Sr. Director/Head of Clinical Pharmacology at the same company.

Before joining Vir Biotechnology, Inc., Maribel worked at QED Therapeutics as the Sr. Director, Clinical Pharmacology and DMPK, where they implemented strategies and oversaw CROs for bioanalytical development. Maribel also held the role of Director, Clinical Pharmacology and DMPK at the same company.

Maribel gained valuable experience at Gilead Sciences as the Sr. Clinical Pharmacologist - Team Lead, where they led global drug development strategies and managed multiple projects in various therapeutic areas.

At Novartis, they served as the Clinical Pharmacology Manager - Oncology, leading clinical pharmacology studies and contributing expert pharmacokinetic input to regulatory documents.

Prior to that, Maribel worked at Actelion as a Clinical Pharmacologist, where they led phase I studies and provided expertise in cross-functional teams.

Maribel started their career as a Research Associate at One Lambda, Inc. | A Thermo Fisher Scientific Brand and also worked as a Manufacturing Associate at Amgen.

Maribel completed their PhD dissertation research at UCSF, focusing on translational research of uremic toxins effects on drug disposition. Maribel was also a Fulbright Fellow at The Fulbright Program.

Maribel Reyes, PhD earned their B.S. in Pharmacology from UC Santa Barbara in 2002. Later, they pursued their PhD in Pharmaceutical Sciences with a specialization in DMPK and Drug Transporters at the University of California, San Francisco from 2005 to 2010.